Low-Dose Cyclophosphamide and Piroxicam Inhibit Growth, Migration, and Invasion of Canine Oral Malignant Melanoma Cell LineNan Choisunirachon(The University of Tokyo), Takayuki Nakagawa(Wakayama Medical University)The Thai Journal of Veterinary MedicineSeptember 1, 201510.56808/2985-1130.2661Cited by 1SaveCiteExport RISWatch citationsRelated PapersLenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway‐induced resistance to vascular endothelial growth factor receptor inhibitor|Cancer Science|2014|39